Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study
Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands
Erlotinib in lung cancer - molecular and clinical predictors of outcome
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Protein-altering germline mutations implicate novel genes related to lung cancer development
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis
